The Brief

Insilico Medicine, a leading artificial intelligence (AI) biotech at the forefront of drug discovery & development, were seeking their first Head of Investor Relations (IR) leader, to oversee future public offering diligence and financial growth planning at their new Boston site.

The Solution

Working with the Head of Global HR, we agreed to lead the search efforts utilizing our expertise within the Boston biotech & life science investor relations talent pool, working on our partnership model.

‍

The Outcome

In less than 4 weeks, Mason Harding enabled Insilico Medicine to recruit a high calibre Head of IR, who working directly with the C-suite leadership team, is already adding unsurpassable value to the IR function.

‍

Adam was extremely helpful throughout the process and is a top tier recruiter! He maintained consistent and open communication at all times and knows the industry space well!

Thomas Leichner - Head of Investor Relations & Growth at Insilico Medicine